Market Overview:
Western blotting is a widely used biochemistry and immunology technique that is used to detect specific proteins in a sample of tissue homogenate or extract. It provides quick, quantitative and qualitative data about expression analysis and post translational modifications of proteins.
The global Western Blotting Market is estimated to be valued at US$ 759.5 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Secondary antibody conjugates (SACs) dominates the western blotting market owing to its high specificity and sensitivity. Furthermore, technological advancements like fluorescent substrates instead of chemiluminescent substrates are gaining traction. Automated western blotting systems provide consistency, reproducibility and quantitative analysis of blots, thereby driving their demand. Growing applications of proteomics and biomarker research will also support the western blotting market growth over the forecast period.
SWOT Analysis
Strength: Western blotting allows for the detection and quantification of specific proteins in a given sample. It is a well established technique with standardized protocols.
Weakness: Western blotting is a time-consuming and labor intensive technique. It requires multiple steps for protein extraction, separation, and transfer before detection.
Opportunity: The rising prevalence of chronic and infectious diseases is driving the demand for advanced protein analysis techniques like western blotting for diagnostic and research purposes.
Threats: Alternative protein detection and quantification techniques like ELISA are gaining popularity due to being less time-consuming and complex than western blotting. Stringent regulations associated with the use of hazardous chemicals is also a challenge.
Key Takeaways
The global western blotting market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing demand for advanced proteomics research and disease diagnostics.
North America dominated the global market in 2022 owing to presence of major players and availability of funding for proteomics research. Asia Pacific is anticipated to be the fastest growing region due to rising R&D investments and improving healthcare infrastructure across China, India and other developing nations.
Key players operating in the western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it